Dickran Kazandjian, MD¹, Christin DeStefano, MD², Alexander Dew, DO, MS^3*, Elizabeth Hill, MD^4*, Katie Thoren, PhD, DABCC FAACC^5* and Ola Landgren⁶

¹Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami
²Walter Reed National Military Medical Center, Chevy Chase, MD
³Walter Reed National Military Medical Center, Bethesda, MD
⁴Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
⁵Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶Sylvester Comprehensive Cancer Center, Miami, FL

Moazzam Shahzad, MD^1,2, Zobia Farooq^1,3*, Amina Akram, MD^1,3*, Ben Ponvilawan, MD^1,3*, Rimsha Riaz^1,3*, Mashood Ahmad Farooqi^1,3*, Saba Ambreen Awan^1,3*, Sibgha Gull Chaudhary, MD^1,3*, Iqra Anwar, MBBS^1,3*, Shajadi Patan, MD^1,3*, Muhammad Kashif Amin, MD^1,3,4*, Leyla O. Shune, MD^1,4,5, Al-Ola Abdallah, MD^1,3,4, Joseph P. McGuirk, DO^1,3,4 and Muhammad Umair Mushtaq^1,3,4

¹Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
²Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵University of Kansas Medical Center, Kansas City, KS

Okan Cetin, MD^1*, Patric Teodorescu, MD^2*, Andrew Staron, MD³, Vaishali Sanchorawala³ and Raphael E. Szalat, MD, PhD⁴

¹Department of Medicine, Istanbul University School of Medicine, Istanbul, AL, Turkey
²Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁴Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA

Craig C. Hofmeister, MD¹, Vikas A. Gupta, MD PhD¹, Nisha S. Joseph, MD¹, Sagar Lonial, MD^1*, Madhav V. Dhodapkar, MD PhD¹, Ajay K. Nooka, MD, MPH² and Jonathan L. Kaufman, MD¹

¹Winship Cancer Institute of Emory University, Atlanta, GA
²Winship Cancer Institute of Emory University, Atlanta

Eirini Katodritou^1*, Efstathios Kastritis, MD^2*, Dimitra Dalampira, MD^3*, Nikolaos Kanellias^2*, Vasiliki Labropoulou, MD^4*, Gerasimos Kyriakidis^5*, Vasiliki Douka^6*, Sosana Delimpasi, MD^7*, Dionysios Stoumpos^8*, Emmanouil Spanoudakis, MD, PhD^9*, Sotirios G. Papageorgiou, MD, PhD^10*, Despina Fotiou, MD^2*, Magdalini Migkou, MD^2*, Annita Ioanna Gkioka, MD^11*, Theodora Triantafyllou, MD^1*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^2*, Theodosia Papadopoulou, MD^1*, Kyriaki Tsirou, MD^1*, Aggeliki Sevastoudi, MD^1*, Aikaterini Daiou^1*, Foteini Theodorakakou, MD^2*, Nikolaos Giannakoulas, MD, PhD^12*, Vasiliki Pappa, MD, PhD¹⁰, Chrysavgi Lalayanni, MD^6*, Anastasia Pouli, MD, PhD⁵, Marie-Christine Kyrtsonis, MD¹¹, Maria Kotsopoulou, MD^8*, Evgenia Verrou^1*, Maria Gavriatopoulou^2*, Evangelos Terpos, MD, PhD¹³ and Meletios-Athanasios Dimopoulos²

¹Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, AL, Greece
⁴Division of Hematology, University of Patras, Medical School, Patras, Greece
⁵Department of Hematology, Agios Savvas Cancer Hospital, Athens, Greece
⁶Department of Hematology and Bone Marrow Transplantation Unit, Papanikolaou General Hospital, Thessaloniki, Greece
⁷Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁸Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece
⁹Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
¹⁰Department of Hematology, Attikon General Hospital, Athens, Greece
¹¹First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
¹²Department of Hematology, University of Thessaly, Larissa, Greece
¹³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece

Foteini Theodorakakou, MD^1*, Despina Fotiou, MD^1*, Vasiliki Spiliopoulou, MD^1*, Magdalini Migkou, MD^1*, Panagiotis Malandrakis, MD^1*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Maria Roussou, MD^1*, Nikolaos Kanellias^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Irene Solia, MD^1*, Asimina Papanikolaou, MD^2*, Charikleia Gakiopoulou, MD^3*, Maria Gavriatopoulou^1*, Evangelos Terpos, MD, PhD⁴, Meletios-Athanasios Dimopoulos¹ and Efstathios Kastritis, MD^5*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Hematopathology Department, Evangelismos General Hospital, Athens, Greece
³1st Department of Pathology, National & Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece

Efstathios Kastritis, MD^*, Panagiotis Malandrakis, MD^*, Irene Solia, MD^*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^*, Foteini Theodorakakou, MD^*, Vasiliki Spiliopoulou, MD^*, Despina Fotiou, MD^*, Magdalini Migkou, MD^*, Nikolaos Kanellias^*, Maria Roussou, MD^*, Evangelos Eleutherakis-Papaiakovou, MD^*, Christine-Ivy Liacos, MS^*, Nefeli Mavrianou Koutsoukou^*, Katerina Chrisostomidou^*, Maria Gavriatopoulou^*, Evangelos Terpos, MD, PhD and Meletios-Athanasios Dimopoulos

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Catherine Ma^1,2*, Fumou Sun, PhD^3*, Clyde Bailey, BS^3*, Hongwei Xu, DDS^3*, Samer Al Hadidi, MD, MSc⁴, Carolina Schinke, MD³, Maurizio Zangari, MD³, Sharmilan Thanendrarajan, MD³, Frits van Rhee, MD, PhD³, John D Shaughnessy, Jr, PhD^3* and Fenghuang Zhan, MD³

¹Department of Internal Medicine, University of Arkansas for Medical, Little Rock, AR
²Coppell High School, Coppell, TX
³Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁴University of Arkansas for Medical Sciences, Little Rock, AR

Jeffrey Thompson, PhD, MS^1*, Julia Catini, PharmD^1*, David Ouyang, MD^2*, I-Min Chiu, MD, PhD^2* and Candida Cristina Quarta, MD^1*

¹Alexion, AstraZeneca Rare Disease, Boston, MA
²Cedars-Sinai Medical Center, Los Angeles, CA

Sawyer Bawek, DO¹, Janine M. Joseph, MS, MBA^2*, Alan Hutson, PhD, MA^2*, Sarah Parker, BS^2*, Joseph D. Tario Jr, Ph.D.^3*, Hamza Hassan, MD^2*, Scott I. Abrams, PhD^2* and Jens Hillengass, MD, PhD⁴

¹University at Buffalo, Buffalo, NY
²Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Pathology & Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Medicine - Myeloma, Roswell Park, Buffalo, NY

Yuhang Song^1*, Yang Liu^2*, Junru Liu^3*, Juan Li, PhD⁴, Jin Lu, MD, PhD^5* and Junling Zhuang⁶

¹Hematology, Peking union medical college hospital, Beijing, CHN
²National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
³Hematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, CHN
⁴The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
⁵Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology, Beijing, China
⁶Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China

Evgenia Granina, MD, MBA¹, Joel Henderson, MD, PhD^2*, Kimberly A. Bertrand, Sc.D.^3*, Vaishali Sanchorawala^4,5,6 and Raphael E. Szalat, MD, PhD⁷

¹Boston Medical Center, Boston, MA
²Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston
³Boston University, Boston, MA
⁴Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA
⁵Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁶Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁷Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA

Eli Muchtar, MD¹, Angela Dispenzieri, MD¹, Vaishali Sanchorawala², Hamza Hassan, MD^3*, Raphael Mwangi, MS^4*, Matthew J. Maurer, DSc⁴, Francis Buadi, MD¹, Hans C. Lee, MD⁵, Muzaffar H. Qazilbash, MD⁶, Andrew Kin, MD⁷, Jeffrey A. Zonder, MD ⁸, Sally Arai, MD⁹, Michelle M Chin, MS¹⁰, Rajshekhar Chakraborty^11*, Suzanne Lentzsch, MD, PhD¹², Hila Magen^13*, Eden Shkury^13*, Caitlin Sarubbi, MD^14*, Heather J. Landau, MD¹⁵, Stefan Schonland^16*, Ute Hegenbart, MD^16* and Morie A. Gertz, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA
⁴Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁵Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁸Karmanos Cancer Institute, Detroit, MI
⁹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
¹⁰Stanford University, Stanford, CA
¹¹Columbia University Irving Medical Center, New York, NY
¹²Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
¹³Sheba Medical Center, Ramat Gan, Israel
¹⁴Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY
¹⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁶Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany

Atsushi Uehara, MD^1*, Fuminari Fujii, M.D.^2*, Hajime Sakuma, M.D.^2*, Mitsuaki Oura, M.D.^2*, Masanori Toho, MD^2*, Daisuke Ikeda, M.D.^3*, Rikako Tabata, M.D.^2*, Kentaro Narita, M.D.^3*, Masami Takeuchi, M.D.^2* and Kosei Matsue, M.D., Ph.D.²

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, Japan
²Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan
³Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan

Hirokazu Miki^1*, Hiroki Takanari^2*, Shin-ichro Yanagiya^2*, Mizuki Yoshimoto^3*, Yusaku Maeda^4*, Ryohei Sumitani^4*, Masahiro Oura^4*, Kimiko Sogabe^4*, Hikaru Yagi^4*, Mamiko Takahashi^5*, Takeshi Harada, MD, PhD⁴, Shiro Fujii^4*, Shingen Nakamura^6*, Yoshimi Bando^7*, Koichi Tsuneyama^8*, Masahiro Abe^5* and Ken-ichi Matsuoka, MD, PhD^4*

¹Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan
²Division of Interdisciplinary Research for Medicine and Photonics, Institute of Post-LED Photonics, Tokushima University, Tokushima, Japan
³Graduate School of Medical Sciences, Tokushima University, Tokushima, Japan
⁴Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
⁵Department of Hematology, Kawashima Hospital, Tokushima, Japan, Tokushima, Japan
⁶Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, Tokushima, Japan
⁷Division of Pathology, Tokushima University Hospital, Tokushima, Japan, Tokushima, Japan
⁸Department of Pathology and Laboratory Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, Tokushima, Japan

Jahanzaib Khwaja^1,2, Sriram Ravichandran^1*, Darren Foard^2*, Ana Martinez-Naharro^2*, Lucia Venneri^2*, Marianna Fontana^2*, Carol Whelan^2*, Philip N Hawkins^2*, Julian Gillmore^2*, Helen J Lachmann^2*, Shameem Mahmood^2*, Shirley D'Sa, MD(Res)^1* and Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath^1,2

¹University College London Hospital, London, United Kingdom
²Royal Free London Hospital, National Amyloid Centre, London, United Kingdom

Xuejiao Yin^1*, Yi Liu^1*, Hongyan Tong, M.D.^2* and Liangshun You, MD^1*

¹Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²Hematology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China